- Home
- IKT vs AEYE Comparison
IKT vs AEYE Comparison
Compare IKT & AEYE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IKT
- AEYE
- Stock Information
- Founded
- IKT 2008
- AEYE 2005
- Country
- IKT United States
- AEYE United States
- Employees
- IKT N/A
- AEYE N/A
- Industry
- IKT Biotechnology: Pharmaceutical Preparations
- AEYE Computer Software: Prepackaged Software
- Sector
- IKT Health Care
- AEYE Technology
- Exchange
- IKT Nasdaq
- AEYE Nasdaq
- Market Cap
- IKT 140.5M
- AEYE 147.1M
- IPO Year
- IKT 2020
- AEYE N/A
- Fundamental
- Price
- IKT $1.94
- AEYE $11.65
- Analyst Decision
- IKT Buy
- AEYE Strong Buy
- Analyst Count
- IKT 2
- AEYE 5
- Target Price
- IKT $8.00
- AEYE $26.40
- AVG Volume (30 Days)
- IKT 529.3K
- AEYE 72.6K
- Earning Date
- IKT 08-13-2025
- AEYE 07-24-2025
- Dividend Yield
- IKT N/A
- AEYE N/A
- EPS Growth
- IKT N/A
- AEYE N/A
- EPS
- IKT N/A
- AEYE N/A
- Revenue
- IKT N/A
- AEYE $36,851,000.00
- Revenue This Year
- IKT N/A
- AEYE $20.16
- Revenue Next Year
- IKT N/A
- AEYE $18.74
- P/E Ratio
- IKT N/A
- AEYE N/A
- Revenue Growth
- IKT N/A
- AEYE 16.52
- 52 Week Low
- IKT $1.12
- AEYE $8.91
- 52 Week High
- IKT $4.20
- AEYE $34.85
- Technical
- Relative Strength Index (RSI)
- IKT 52.68
- AEYE 47.96
- Support Level
- IKT $1.81
- AEYE $11.55
- Resistance Level
- IKT $2.09
- AEYE $12.56
- Average True Range (ATR)
- IKT 0.14
- AEYE 0.56
- MACD
- IKT 0.02
- AEYE 0.04
- Stochastic Oscillator
- IKT 71.70
- AEYE 43.23
About IKT Inhibikase Therapeutics Inc.
Inhibikase Therapeutics Inc is a a clinical-stage pharmaceutical company developing protein kinase inhibitor therapeutics to modify the course of Parkinson's disease (PD), Parkinson's-related disorders and other diseases of the Abelson Tyrosine Kinases. Its multi-therapeutic pipeline has a primary focus on neurodegeneration and its program utilizing Risvodetinib (also known as IkT-148009), a selective inhibitor of the non-receptor Abelson Tyrosine Kinases, targets the treatment of Parkinson's disease inside and outside the brain as well as other diseases that arise from Abelson Tyrosine Kinases.
About AEYE AudioEye Inc.
AudioEye Inc is a software solution provider delivering immediate ADA and WCAG accessibility compliance at scale. Through patented technology, subject matter expertise and proprietary processes, it is eradicating all barriers to digital accessibility, helping creators get accessible and supporting them with ongoing advisory and automated upkeep. Trusted by the ADP, Tommy Hilfiger, A360 Media, Samsung, Landry's and others. It helps everyone identify and resolve issues of accessibility and enhance user experiences, automating digital accessibility for the widest audiences.